Fulvestrant Labatec 250 mg/5 ml

Fulvestrant Labatec 250 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 68761. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 November 2022 and the authorisation is limited until 21 November 2027. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 68761
  • Synthetic medicines
Authorisation data
Authorisation number68761
NameFulvestrant Labatec 250 mg/5 ml
Full nameFulvestrant Labatec 250 mg/5 ml, Solution pour injection en seringue pré-remplie
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation22 November 2022
Authorisation validity21 November 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Fulvestrant Labatec 250 mg/5 ml, Solution pour injection en seringue pré-remplieB22 November 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Fulvestrant Labatec 250 mg/5 ml authorised in Switzerland?

Yes. Fulvestrant Labatec 250 mg/5 ml is authorised by Swissmedic under authorisation number 68761, data as of 01 September 2026. The authorisation is limited until 21 November 2027.

Which dispensing category does Fulvestrant Labatec 250 mg/5 ml have?

Fulvestrant Labatec 250 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fulvestrant Labatec 250 mg/5 ml?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com